3 Trends I’m Watching in Corporate Finance

Amit Hazan Head of Corporate Finance and Banking Relations

3 Trends

Amit Hazan, Teva’s Head of Corporate Finance and Banking Relations reveals the fast-paced global trends he’s watching right now

Transcript for Amit Hazan: 3 Trends I’m Watching in Corporate Finance Video

The thing I like the most about my job is the fact that it's global, it's dynamic and I have the chance to work with the most talented people in Teva's Finance and in the banking industry.

My name is Amit Hazan and I'm working in Teva's headquarters in Tel Aviv, Israel. I'm managing Teva's corporate financing activities and banking relations. In other words, it means that I work with the world's largest banks in order to make sure Teva has enough access to liquidity and to the debt and capital markets at any given point in time.

The 3 trends I'm excited about are the evolution of green financing solutions, cash flow optimization and continuous hedging against macro-economic headwinds.

The first trend I'm watching is about the evolution of green financing solutions. Two of the world’s greatest challenges these days are climate change and lack of access to affordable medicines in certain parts of the world. We in Teva do a lot of work in order to tackle and to address these two concerns. I'm proud to say that in Teva's Finance we managed to accelerate Teva's sustainability journey by linking between our financial results and our environmental results. Back in 2021, we issued 5 billion dollars of sustainability linked bonds, followed by another 2 and a half billion in 2023. Issuing sustainability linked bonds creates a strong link between your financial results and your sustainability targets and by that, it incentivizes the company to achieve its sustainability targets.

The second trend I'm watching is cashflow optimization. We in Teva, and you can see it across all the industry, are working to strengthen our cashflows and by that creating growth opportunities. Given the recent developments in the markets, especially the dramatically increasing interest rates, money became more valuable. This means that the cost of funding from external resources became more and more expensive. So companies, instead of going to seek for external funding which is now more expensive, will first seek to optimize their internal cash flows by unlocking working capital.

The third trend I'm watching is the continuous hedging against macro-economic headwinds. In the past few years, the world is facing tremendous macro-economic   headwinds, unprecedented and unexpected. It started with COVID, followed by high energy prices, high inflation and then followed by higher interest rates. In Teva, our number one priority is to ensure that our 200 million patients have access to their medicines every day, anytime, anywhere. We in Teva Finance engage in multiple hedging strategies through various hedging instruments in order to protect the company's financials against foreign exchange risks, interest rates risks and higher energy prices. Securing the company's financials allows Teva to keep supporting its patients every day.

Amit Hazan: 3 Trends I’m Watching in Corporate Finance

The 3 trends I'm excited about are the evolution of green financing solutions, cash flow optimization and continuous hedging against macro-economic headwinds.

 

“The thing I like the most about my job is the fact that it's global, it's dynamic and I have the chance to work with the most talented people in the banking industry.”

The evolving world of green finance solutions, fast-paced cashflow optimization and the continuous hedging against macro-economic headwinds are three of the global finance trends that are on Amit Hazan’s agenda. Hear him discuss how Teva is navigating this new world of unprecedented change.


Find out more:


You might also be interested


Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana


Mark DeStefano, Director of Global Technology Innovation for the CPD R&D group at Teva

3 Trends I’m Watching in Drug Delivery Devices


Beryl Ojwang, MD, MBA, MPH, Global Associate Medical Director in Neuroscience, shares how technology helps generate patient insights for Teva scientists.

“AI helps us better understand and support patient needs”


Konstantina Katcheves, SVP Innovative Business Development

3 Trends

3 Trends I’m Watching in Pharma Business Development


Two women standing in a forest

Goodbye? More Like “See You Later!” Teva’s Boomerang Employees


Navdeep Boparai

"I have learned more from ‘successful failures’ than clear-cut wins"



3 Trends I’m Watching in Clinical Research Studies



Where Big Pharma Meets Academia: Key Trends I’m Watching


Placid Jover with Teva’s Spanish HR and payroll team

“Real Progress Comes Not from Extraordinary Moments but from the Everyday”


on the meeting

Why Diversity in Clinical Trials is So Important